🎯 check Eltanexor (KPT-8602) product page
Eltanexor (KPT-8602) is a selective XPO1 inhibitor. It affects MAPK, STAT3, and p53 signaling pathways by binding to XPO1 and blocking nuclear export, effectively inhibiting cancer cell proliferation and promoting apoptosis.